 |
|
Anti-Müllerian Hormone Negatively Regulates Osteoclast Differentiation by Suppressing the Receptor Activator of Nuclear Factor-κB Ligand Pathway
Jung Ha Kim, Yong Ryoul Yang, Ki-Sun Kwon, Nacksung Kim
J Bone Metab. 2021;28(3):223-230. Published online 2021 Aug 31 DOI: https://doi.org/10.11005/jbm.2021.28.3.223
|
|
Citations to this article as recorded by
 Anti-Müllerian hormone: biology and role in endocrinology and cancers
Marek Gowkielewicz, Aleksandra Lipka, Wojciech Zdanowski, Tomasz Waśniewski, Marta Majewska, Carsten Carlberg
Frontiers in Endocrinology.2024;[Epub] CrossRef Associations of AMH in Midreproductive Years with Bone Mineral Density and Turnover Markers in Midlife
Siwen Wang, Elaine W Yu, Marie-France Hivert, Sheryl L Rifas-Shiman, Jan L Shifren, Maryam Kazemi, Emily Oken, Jorge E Chavarro
The Journal of Clinical Endocrinology & Metabolism.2024;[Epub] CrossRef Anti-Müllerian Hormone promotes human osteoblast differentiation and calcification by modulating osteogenic gene expression
Francesca Liuzzi, Marilena Taggi, Serena De Carlini, Antonio La Marca
Gynecological Endocrinology.2023;[Epub] CrossRef The ATF3–OPG Axis Contributes to Bone Formation by Regulating the Differentiation of Osteoclasts, Osteoblasts, and Adipocytes
Jung Ha Kim, Kabsun Kim, Inyoung Kim, Semun Seong, Jeong-Tae Koh, Nacksung Kim
International Journal of Molecular Sciences.2022; 23(7): 3500. CrossRef Loss of Anti-Müllerian Hormone Signaling in Mice Affects Trabecular Bone Mass in a Sex- and Age-Dependent Manner
Christiane van As, Marijke Koedam, Anke McLuskey, Piet Kramer, Najiba Lahlou, Bram C J van der Eerden, Jenny A Visser
Endocrinology.2022;[Epub] CrossRef
|